PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medicine, Division of Nephrology, Transplant Immunology Laboratory, Transplant Immunotherapy Program, United States.\', \'Department of Clinical Transformation, Cedars-Sinai Medical Center, Los Angeles, California, United States.\', \'Department of Medicine, Division of Nephrology, Transplant Immunology Laboratory, Transplant Immunotherapy Program, United States. Electronic address: stan.jordan@cshs.org.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1201-9712(21)00143-010.1016/j.ijid.2021.02.057
?:hasPublicationType
?:journal
  • International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
is ?:pmid of
?:pmid
?:pmid
  • 33609773
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Tocilizumab treatment in critically ill patients with COVID-19: A retrospective observational study.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33609773>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33609773>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all